Book chapter · 2011
Controversies in Empiric Therapy of Febrile Neutropenia
Humana Press eBooks, 105–111 · Published 26 April 2011 · DOI 10.1007/978-1-60761-644-3_9
In brief
“Controversies in Empiric Therapy of Febrile Neutropenia” is a 2011 book chapter by John R. Wingard, published in Humana Press eBooks. OpenAlex counts 0 citations as of 19 November 2026. The publisher's version is not open access, and OpenAlex records no free legal copy.
- Citations
- 0
- References
- 73
- Authors
- 1
Abstract
Antineoplastic chemotherapy regimens induced myelosuppression was quickly recognized as a major limitation to the full utility of cytotoxic drug regimens targeting cancer. Measures taken to mitigate harm from myelosuppression have led to a number of controversies over the years. The first controversy faced by clinicians was whether or not empiric antibiotic therapy for febrile neutropenia… Read the full abstract at the publisher.
Excerpt. This paper is not open access.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Wingard, J. R. (2011). Controversies in Empiric Therapy of Febrile Neutropenia. Humana Press eBooks, 105–111. https://doi.org/10.1007/978-1-60761-644-3_9
MLA 9
Wingard, John R. “Controversies in Empiric Therapy of Febrile Neutropenia.” Humana Press eBooks, 2011, pp. 105–111. https://doi.org/10.1007/978-1-60761-644-3_9.
Chicago
Wingard, John R. 2011. “Controversies in Empiric Therapy of Febrile Neutropenia.” Humana Press eBooks: 105–111. https://doi.org/10.1007/978-1-60761-644-3_9.
Harvard
Wingard, J. R. (2011) ‘Controversies in Empiric Therapy of Febrile Neutropenia’, Humana Press eBooks, pp. 105–111. doi:10.1007/978-1-60761-644-3_9.
IEEE
J. R. Wingard, “Controversies in Empiric Therapy of Febrile Neutropenia,” Humana Press eBooks, pp. 105–111, 2011, doi: 10.1007/978-1-60761-644-3_9.
BibTeX
@incollection{wingard2011controversies,
title = {{Controversies in Empiric Therapy of Febrile Neutropenia}},
author = {Wingard, John R.},
booktitle = {Humana Press eBooks},
publisher = {Humana Press},
year = {2011},
pages = {105--111},
doi = {10.1007/978-1-60761-644-3_9},
url = {https://doi.org/10.1007/978-1-60761-644-3_9}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Health Sciences › Medicine › Oncology › Neutropenia and Cancer Infections
- febrile neutropenia
- empirical antibiotic therapy
- myelosuppression
- cancer chemotherapy
- antibiotic resistance
- superinfection
- antifungal therapy
- neutropenic enterocolitis
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Wingard, J. R. (2011). Controversies in Empiric Therapy of Febrile Neutropenia. Humana Press eBooks, 105–111. https://doi.org/10.1007/978-1-60761-644-3_9
How many times has this paper been cited?
0 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.
Who wrote this paper?
John R. Wingard.
What is the DOI of this paper?
10.1007/978-1-60761-644-3_9, permanently at https://doi.org/10.1007/978-1-60761-644-3_9. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.